Researchers in the Netherlands and Latin America have identified a new score using existing serum biomarkers to detect early stages of hepatocellular carcinoma.
Timely detection is paramount, stressed researcher André Boonstra, PhD, an experimental hepatologist at Erasmus Medical Center, in Rotterdam, Netherlands. “Early detection significantly improves a patient’s chances of survival,” Dr. Boonstra said, noting that in early HCC stages, treatment with surgical